ArticleJournal of computer-aided molecular design2025
DeepTargetClass: a web-based platform for predicting protein target classes of small molecules.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- MERS-Mpro Predictor: A Machine Learning-Based Tool for Rapid Screening of Potential MERS-CoV Main Protease Inhibitors.International journal of molecular sciences · 2026Article
- An Explainable 2D-QSAR Machine Learning Approach for Predicting COX-2 Inhibitory Activity Using Molecular Fingerprints.Pharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The identification of protein target classes is a key step in drug discovery, as it enables prioritization of screening campaigns and supports target-based drug repurpose. In this study, we developed a deep-learning pipeline based on a multilayer perceptron (MLP) trained on 15,804 curated compounds representing four major pharmacological target classes: G protein-coupled receptors (GPCRs), kinases, nuclear receptors, and transporters. Using extended connectivity fingerprints (ECFP4) as molecular descriptors, the model achieved 96% accuracy in internal cross-validation and 87% accuracy on an external test set, demonstrating performance comparable to ensemble classifiers such as Random Forest, XGBoost, and LightGBM. Class-specific F1 scores confirmed robust and balanced predictions across GPCR, kinase, nuclear receptor, and transporter categories. Model interpretability was addressed using SHAP values, which highlighted pharmacophore-like substructures consistent with known ligand-target interactions. Application to reference drugs further validated predictive utility, with correct assignment of most compounds to their canonical protein target class. The final MLP model was deployed as a user-friendly web application to facilitate accessible protein class prediction for novel compounds. Overall, this work presents a reliable and interpretable computational framework to support target-class-based drug discovery and repositioning.
Indexed as
Identifiers
41331195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.